Symbol
| CCND3
| contributors: mct - updated : 30-08-2016
|
HGNC name
| cyclin D3
|
HGNC id
| 1585
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
with CDKN1B in agressive B cell lymphoma, glioblastoma and gliosarcoma | tumoral
|  
| translocation
|  
|  
|
in multiple myeloma | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | hemopathy | | |
potential therapeutic target for germinal center-derived B-cell malignancies |
| | | |
| Ccnd3(-/-) mice exhibit a B-cell-intrinsic defect in germinal center maturation and fail to generate an affinity-matured IgG response | |
|